White Matter Integrity and Nicotine Dependence: Evaluating Vertical and Horizontal Pleiotropy

Zhenyao Ye, Chen Mo, Song Liu, Kathryn S. Hatch, Si Gao, Yizhou Ma, L. Elliot Hong, Paul M. Thompson, Neda Jahanshad, Ashley Acheson, Hugh Garavan, Li Shen, Thomas E. Nichols, Peter Kochunov, Shuo Chen, Tianzhou MaFrontiers in Neuroscience 2021 · DOI

TL;DR

This study investigates the complex genetic underpinnings of nicotine dependence and its relationship with white matter (WM) integrity in the brain. Using advanced causal inference methods on UK Biobank data, researchers found that genetic factors influence nicotine dependence through two distinct pathways: either by altering WM integrity first, which then affects smoking behavior, or by directly influencing smoking behavior, which subsequently impacts WM integrity.

What Problem Does This Paper Address?

Nicotine dependence is a major public health concern with significant genetic contributions, but its precise neurogenetic mechanisms remain elusive. While smoking is known to affect brain structure, particularly white matter integrity, the directionality of this relationship and the role of genetics in mediating it are not fully understood. Specifically, it's unclear whether genetic predispositions to nicotine dependence cause changes in white matter that then lead to smoking, or if genetic factors directly influence smoking behavior, with the resulting chronic smoking then damaging white matter. This paper aims to disentangle these complex causal relationships by exploring pleiotropic pathways (where a single gene influences multiple traits) between genetics, white matter integrity, and nicotine dependence.

Methods

The researchers employed a sophisticated imaging genetics approach combining genome-wide association studies (GWAS) with causal inference and mediation analysis.

  1. GWAS: They first conducted GWAS for two key smoking phenotypes: smoking status (current vs. never smokers) and cigarettes per day (CPD). This identified genetic variants (SNPs) associated with smoking behavior.
  2. Pleiotropy Identification: They then looked for SNPs that were associated with both smoking phenotypes and white matter integrity (measured by fractional anisotropy, FA). These are termed "pleiotropic" variants.
  3. Causal Pathway Discovery: To distinguish between different causal models, they used a novel approach that combined conditional independence tests and a Bayesian Information Criterion (BIC) score-based model selection. This allowed them to test three competing hypotheses:
  4. Model 0 (Horizontal Pleiotropy): Genetics independently affect both smoking and WM integrity.
  5. Model 1 (Vertical Pleiotropy): Genetics → WM integrity → Smoking.
  6. Model 2 (Vertical Pleiotropy): Genetics → Smoking → WM integrity.
  7. Mediation Analysis: For variants showing vertical pleiotropy, they performed detailed mediation analysis to quantify the indirect effects of genetics on smoking (via WM integrity) or vice versa.

Datasets

The study utilized data from the UK Biobank (UKBB), a large-scale, prospective epidemiological study. The UKBB provided:

  • Phenotypic Data: Information on smoking status (SS) and cigarettes per day (CPD) for approximately 500,000 participants.
  • Genomic Data: Genotype data from over 90 million single-nucleotide variants (SNVs) for a substantial subset of participants.
  • Neuroimaging Data: Diffusion tensor imaging (DTI) data, specifically fractional anisotropy (FA) measures of white matter integrity, for a subset of participants.

The analysis focused on individuals of white ethnicity with complete data for genetics, smoking phenotypes, and WM integrity.

Key Insights and Ideas

  • WM Integrity is a Mediator, Not Just an Outcome: The study strongly suggests that white matter integrity plays a crucial role as a mediator in the genetic pathways leading to nicotine dependence, challenging a purely outcome-based view of smoking's effects on the brain.
  • Two Distinct Genetic Pathways: There isn't a single genetic story for nicotine dependence and brain structure. Instead, distinct sets of genes appear to operate through different causal pathways: one where genetics affect WM integrity first, and another where genetics directly influence smoking behavior.
  • Gene-Specific Mechanisms: The identified pleiotropic SNPs are concentrated in specific genes, notably NCAM1 (for the Genetics → WM integrity → Smoking pathway) and IREB2 (for the Genetics → Smoking → WM integrity pathway), providing concrete targets for further investigation into the biological mechanisms.
  • Competitive Mediation: For both pathways, the study found evidence of "competitive mediation." This means that while genetics might influence smoking via WM integrity (or vice versa), there's also a direct genetic effect on the other trait that works in the opposite direction, creating a complex interplay.

Key Results

  • Smoking Associated with Reduced WM Integrity: Consistent with prior research, current smokers showed reduced WM integrity (lower FA) in multiple brain regions.
  • 272 SNPs for Genetics → WM integrity → SS: The study identified 272 pleiotropic SNPs where genetic effects on smoking status (SS) were mediated by FA in the right tract of the anterior limb of the internal capsule (ALIC-R). The gene NCAM1 was a major locus for these variants.
  • 22 SNPs for Genetics → CPD → WM integrity: Conversely, 22 pleiotropic SNPs showed that genetic effects on cigarettes per day (CPD) were mediated by FA in the ALIC-R and the left posterior corona radiata (PCR-L). The gene IREB2 was a key locus for these variants.
  • Vertical Pleiotropy Dominates: The analysis largely ruled out horizontal pleiotropy, indicating that genetic factors influencing smoking and WM integrity are not acting independently but are linked through causal pathways.

Limitations and Future Work

  • Population Specificity: The study population consisted primarily of individuals of white ethnicity. Future research should aim to replicate these findings in more diverse cohorts to assess generalizability.
  • Heterogeneity in UKBB Data: The UKBB data comes from multiple assessment sites and phases. While efforts were made to account for this, potential heterogeneity might still influence results.
  • Focus on Top Variants: The analysis prioritized SNPs with strong GWAS signals. It's possible that weaker genetic signals, which could also contribute to these pathways, were missed.
  • Future Directions: The authors suggest future research should:
  • Examine the functional roles of NCAM1 and IREB2 in the context of nicotine addiction and brain structure.
  • Investigate how changes in WM integrity might contribute to the broader effects of nicotine on brain function and cognition.
  • Validate these findings in larger, independent cohorts.
  • Explore the implications of these genetic pathways for developing targeted interventions for nicotine dependence.

Summary updated

Abstract

Tobacco smoking is an addictive behavior that supports nicotine dependence and is an independent risk factor for cancer and other illnesses. Its neurogenetic mechanisms are not fully understood but may act through alterations in the cerebral white matter (WM). We hypothesized that the vertical pleiotropic pathways, where genetic variants influence a trait that in turn influences another trait, link genetic factors, integrity of cerebral WM, and nicotine addiction. We tested this hypothesis using individual genetic factors, WM integrity measured by fractional anisotropy (FA), and nicotine dependence-related smoking phenotypes, including smoking status (SS) and cigarettes per day (CPDs), in a large epidemiological sample collected by the UK Biobank. We performed a genome-wide association study (GWAS) to identify previously reported loci associated with smoking behavior. Smoking was found to be associated with reduced WM integrity in multiple brain regions. We then evaluated two competing vertical pathways: Genes → WM integrity → Smoking versus Genes → Smoking → WM integrity and a horizontal pleiotropy pathway where genetic factors independently affect both smoking and WM integrity. The causal pathway analysis identified 272 pleiotropic single-nucleotide polymorphisms (SNPs) whose effects on SS were mediated by FA, as well as 22 pleiotropic SNPs whose effects on FA were mediated by CPD. These SNPs were mainly located in important susceptibility genes for smoking-induced diseases <i>NCAM1</i> and <i>IREB2</i>. Our findings revealed the role of cerebral WM in the maintenance of the complex addiction and provided potential genetic targets for future research in examining how changes in WM integrity contribute to the nicotine effects on the brain.
BibTeX
@inproceedings{ye2021white,
  author = {Zhenyao Ye and Chen Mo and Song Liu and Kathryn S. Hatch and Si Gao and Yizhou Ma and L. Elliot Hong and Paul M. Thompson and Neda Jahanshad and Ashley Acheson and Hugh Garavan and Li Shen and Thomas E. Nichols and Peter Kochunov and Shuo Chen and Tianzhou Ma},
  title = {{White Matter Integrity and Nicotine Dependence: Evaluating Vertical and Horizontal Pleiotropy}},
  booktitle = {Frontiers in Neuroscience},
  year = {2021},
  doi = {10.3389/fnins.2021.738037},
}
Figure